OncoMatch

OncoMatch/Clinical Trials/GIST (Gastrointestinal Stromal Tumor)

GIST (Gastrointestinal Stromal Tumor) Clinical Trials

Recruiting trials·Updated daily from ClinicalTrials.gov

OncoMatch filters GIST (Gastrointestinal Stromal Tumor) trials by the molecular markers that determine eligibility — KIT, PDGFRA, NF1, SDHA, and more. Enter your biomarker results to see only the trials you may qualify for.

Compare eligibility criteria
Biomarker panel

Biomarkers tested in GIST (Gastrointestinal Stromal Tumor) trials

These are the molecular markers most commonly required or evaluated in GIST (Gastrointestinal Stromal Tumor) eligibility criteria. OncoMatch extracts them from each trial's protocol and matches them against your test results.

KITPDGFRANF1SDHASDHB

How OncoMatch finds GIST (Gastrointestinal Stromal Tumor) trials for you

01

AI reads the protocol

Every GIST (Gastrointestinal Stromal Tumor) trial on ClinicalTrials.gov has eligibility criteria written for regulators. OncoMatch uses large language models to extract the structured requirements — biomarkers, stage, prior therapy, and more — from that text.

02

You enter your results

Select GIST (Gastrointestinal Stromal Tumor) and mark your biomarker results — KIT, PDGFRA, NF1 — as positive, negative, or not tested. Your data never leaves your device.

03

See only relevant trials

Results filter instantly. Each trial shows exactly which criteria you meet, which you don't, and which need more information. Bring the list to your oncologist.

Find GIST (Gastrointestinal Stromal Tumor) trials →